eXoZymes (Nasdaq: EXOZ)

📍 Monrovia, United States🗓 Founded 2019👥 38 employees
Biotechnology🌐 exozymes.com
Website LinkedIn
eXoZymes has developed a next gen biomanufacturing platform capable of producing highly valuable natural products. As a historic first, this cell-free platform offers the bioengineering tools and design-control to run nature’s own natural enzyme pathways without living cells. AI is used to genetically optimize the cell-free enzymes - called exozymes - to thrive in a bioreactor outside the cell.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was eXoZymes (Nasdaq: EXOZ) founded?
eXoZymes (Nasdaq: EXOZ) was founded in 2019.
What industry is eXoZymes (Nasdaq: EXOZ) in?
eXoZymes (Nasdaq: EXOZ) operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is eXoZymes (Nasdaq: EXOZ) based?
eXoZymes (Nasdaq: EXOZ) is headquartered in Monrovia, United States.